Glucagon-like peptide 2 (GLP-2) is a recently identified intestinal epithelium-specific growth factor that has been shown to reduce the severity of inflammatory disorders of the intestine in rodent models. Currently Glucagon-Like Peptide 2 is used as a potential therapeutic agent for the human subjects with a broad variety of intestinal diseases characterized by intestinal damage and insufficiency.

Guanosine 5'-triphosphate trisodium salt activates the signal transducing G proteins which are involved in various cellular processes including proliferation differentiation and activation of several intracellular kinase cascades.Proliferation and apoptosis are regulated in part by the hydrolysis of GTP by small GTPases Ras and Rho.

H-Gly-Pro-OH is a dipeptide composed of glycine and proline and is an end product of collagen metabolism.